|
hydroxylysine metabolic process
|
GO_0046946 |
[The chemical reactions and pathways involving hydroxylysine (5-hydroxy-2,6-diaminohexanoic acid), a chiral alpha-amino acid. Hydroxylysine is found in collagen and commonly has galactose and then glucose added sequentially by glycosyltransferases.] |
|
hydroxylysine catabolic process
|
GO_0046948 |
[The chemical reactions and pathways resulting in the breakdown of hydroxylysine (5-hydroxy-2,6-diaminohexanoic acid), a chiral alpha-amino acid.] |
|
azetidine-2-carboxylic acid acetyltransferase activity
|
GO_0046941 |
[Catalysis of the reaction: L-azetidine-2-carboxylic acid + acetyl-CoA = CoA-SH + N-acetyl azetidine-2-carboxylic acid.] |
|
nucleoside monophosphate phosphorylation
|
GO_0046940 |
[The process of introducing one or more phosphate groups into a nucleoside monophosphate to produce a polyphosphorylated nucleoside.] |
|
regulation of icosanoid secretion
|
GO_0032303 |
[Any process that modulates the frequency, rate or extent of the controlled release of an icosanoid from a cell.] |
|
regulation of prostaglandin secretion
|
GO_0032306 |
[Any process that modulates the frequency, rate or extent of the regulated release of a prostaglandin from a cell.] |
|
positive regulation of icosanoid secretion
|
GO_0032305 |
[Any process that activates or increases the frequency, rate or extent of the controlled release of an icosanoid from a cell.] |
|
positive regulation of prostaglandin secretion
|
GO_0032308 |
[Any process that activates or increases the frequency, rate or extent of the regulated release of a prostaglandin from a cell.] |
|
negative regulation of prostaglandin secretion
|
GO_0032307 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of a prostaglandin from a cell.] |
|
ventral midline determination
|
GO_0007371 |
[The regionalization process in which the area where the ventral midline will form is specified.] |
|
ventral furrow formation
|
GO_0007370 |
[Formation of a ventral indentation (furrow) from the blastoderm epithelium, which is internalized to form a tube in the interior of the embryo, marking the start of gastrulation.] |
|
GO_0007373
|
GO_0007373 |
|
|
GO_0007372
|
GO_0007372 |
|
|
anterior midgut invagination
|
GO_0007375 |
[Internalization of the anterior midgut into the interior of the embryo.] |
|
negative regulation of chondrocyte differentiation
|
GO_0032331 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of chondrocyte differentiation.] |
|
negative regulation of cartilage development
|
GO_0061037 |
[Any process that decreases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.] |
|
regulation of chondrocyte differentiation
|
GO_0032330 |
[Any process that modulates the frequency, rate or extent of chondrocyte differentiation.] |
|
posterior midgut invagination
|
GO_0007374 |
[Formation of a cup-shaped invagination at the posterior end of the embryo, bringing the posterior midgut and hindgut primordia into the interior.] |
|
regulation of cartilage development
|
GO_0061035 |
[Any process that modulates the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.] |
|
positive regulation of Lewy body formation
|
GO_0140124 |
[Any process that activates or increases the frequency, rate or extent of Lewy body formation.] |